Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Asthma

  Free Subscription


Articles published in Ann Allergy Asthma Immunol

Retrieve available abstracts of 98 articles:
HTML format



Single Articles


    October 2022
  1. WEINBERGER M
    Can current hospitalization rates for asthma be decreased?
    Ann Allergy Asthma Immunol. 2022;129:401-402.
    PubMed    


  2. WEINBERGER M
    Should asthma evaluation include assessment of small airway function?
    Ann Allergy Asthma Immunol. 2022;129:399-400.
    PubMed    


  3. COLAK Y, Ingebrigtsen TS, Nordestgaard BG, Marott JL, et al
    Plasma immunoglobulin E and risk of exacerbation and mortality in chronic obstructive pulmonary disease: A contemporary population-based cohort.
    Ann Allergy Asthma Immunol. 2022;129:490-496.
    PubMed     Abstract available


    September 2022
  4. CHAN R, Stewart K, Lipworth B
    Airflow obstruction in real life is associated with small airways dysfunction in moderate to severe asthma.
    Ann Allergy Asthma Immunol. 2022 Sep 24. pii: S1081-1206(22)01775.
    PubMed    


  5. SANGKANJANAVANICH S, Pradubpongsa P, Mitthamsiri W, Sangasapaviliya A, et al
    Bifidobacterium infantis 35624 Efficacy in Patients with Uncontrolled Asthma: A Randomized Placebo-Controlled Trial.
    Ann Allergy Asthma Immunol. 2022 Sep 8. pii: S1081-1206(22)01712.
    PubMed    


    August 2022
  6. BIGGS SE, Ownby DR, May KR
    Use of over-the-counter inhaled epinephrine in asthma.
    Ann Allergy Asthma Immunol. 2022 Aug 27. pii: S1081-1206(22)01674.
    PubMed    


  7. PRICE AS, Kennedy JL
    T helper 2 Mechanisms involved in Human Rhinovirus Infections and Asthma.
    Ann Allergy Asthma Immunol. 2022 Aug 21. pii: S1081-1206(22)00695.
    PubMed     Abstract available


  8. LIU J, Yuan MB, Chen YQ, Wang Y, et al
    Global burden of asthma associated with high body mass index from 1990 to 2019.
    Ann Allergy Asthma Immunol. 2022 Aug 21. pii: S1081-1206(22)00694.
    PubMed     Abstract available


  9. CHOW TG, Palka JM, Stone B, Trojan T, et al
    Safety of Subcutaneous Immunotherapy in Patients with Severe Asthma.
    Ann Allergy Asthma Immunol. 2022 Aug 20. pii: S1081-1206(22)00693.
    PubMed     Abstract available


  10. COLETTA C, Grayson MH
    Causation or coincidence? Phenotype of asthma exacerbations during the coronavirus disease 2019 pandemic.
    Ann Allergy Asthma Immunol. 2022;129:131-132.
    PubMed    


    July 2022
  11. BRYANT N, Muehling LM
    T-cell responses in asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Jul 30. pii: S1081-1206(22)00621.
    PubMed     Abstract available


  12. IMAM SF, Zafar S, Oppenheimer J
    SMART in treatment of asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Jul 29. pii: S1081-1206(22)00619.
    PubMed     Abstract available


  13. GREINER B, Hartwell M
    Prevalence and associations between metabolically unhealthy obesity and asthma exacerbations and emergency department usage.
    Ann Allergy Asthma Immunol. 2022 Jul 14. pii: S1081-1206(22)00590.
    PubMed     Abstract available


  14. PATE CA, Zahran HS, Malilay J, Hsu J, et al
    The Shifting Prevalence of Asthma and Allergic Disease in United States Children.
    Ann Allergy Asthma Immunol. 2022 Jul 13. pii: S1081-1206(22)00586.
    PubMed     Abstract available


    June 2022
  15. LEE TY, Petkau J, Mangat N, Safari A, et al
    16-year trends in asthma hospital admissions in Canada.
    Ann Allergy Asthma Immunol. 2022 Jun 29. pii: S1081-1206(22)00540.
    PubMed     Abstract available


  16. DINWIDDIE DL, Kaukis N, Pham S, Hardin O, et al
    Viral infection and allergy status impact severity of asthma symptoms in children with asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Jun 21. pii: S1081-1206(22)00535.
    PubMed     Abstract available


  17. PANETTIERI RA JR, Ledford DK, Chipps BE, Soong W, et al
    Biologic Use and Outcomes Among Adults with Severe Asthma Treated by United States Subspecialists.
    Ann Allergy Asthma Immunol. 2022 Jun 18. pii: S1081-1206(22)00532.
    PubMed     Abstract available


  18. POLIVKA BJ, Huntington-Moskos L, Antimisiaris DE, Cavallazzi RS, et al
    Phenotyping Older Adults with Asthma via Cluster Analysis.
    Ann Allergy Asthma Immunol. 2022 Jun 10. pii: S1081-1206(22)00501.
    PubMed    


  19. RURAN HB, Maciag MC, Murphy SE, Phipatanakul W, et al
    Cross-Sectional Study of Urinary Biomarkers of Environmental Tobacco and E-Cigarette Exposure and Asthma Morbidity.
    Ann Allergy Asthma Immunol. 2022 Jun 7. pii: S1081-1206(22)00499.
    PubMed    


  20. BELLANTI JA, Lanier BQ, Ein D, Finegold I, et al
    The American College of Allergy, Asthma & Immunology: an 80-year legacy of accomplishments (1942-2022), part 3: events and achievements (2012-2022).
    Ann Allergy Asthma Immunol. 2022 Jun 4. pii: S1081-1206(22)00494.
    PubMed    


  21. CHUNG Y, Katial R, Mu F, Cook EE, et al
    Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study.
    Ann Allergy Asthma Immunol. 2022;128:669-676.
    PubMed     Abstract available


    May 2022
  22. SCIOSCIA BG, Lacedonia D, Quarato CMI, Tondo P, et al
    Could Transthoracic Ultrasound be useful to suggest a small airways disease in severe uncontrolled asthma?
    Ann Allergy Asthma Immunol. 2022 May 25. pii: S1081-1206(22)00491.
    PubMed     Abstract available


  23. CHUPP G, Wechsler ME
    Biologic Medications in Asthma: What have we learned from long-term studies?
    Ann Allergy Asthma Immunol. 2022 May 24. pii: S1081-1206(22)00489.
    PubMed    


  24. WANG EA, Goleva E, Ketosugbo K, Kern JA, et al
    Effect of immune checkpoint inhibitors on asthma.
    Ann Allergy Asthma Immunol. 2022 May 24. pii: S1081-1206(22)00487.
    PubMed    


  25. LIPWORTH DB, Stewart MK, Chan DR
    Pragmatic reappraisal of long acting muscarinic antagonists at steps 4/5 for persistent adult asthma: Invited Perspective article for Annals of Allergy, Asthma and Immunology.
    Ann Allergy Asthma Immunol. 2022 May 22. pii: S1081-1206(22)00449.
    PubMed    


  26. HUDDLESTON CM, Slaven JE, Weist AD, Krupp NL, et al
    Increased Healthcare Utilization in Moderate to Severe Asthma Patients Due to Frequent Preferred Medication Changes.
    Ann Allergy Asthma Immunol. 2022 May 21. pii: S1081-1206(22)00448.
    PubMed    


  27. SHERREY J, Biggs S, Dorrian J, Martin J, et al
    Allergic disease, sleep problems and psychological distress in children recruited from the general community.
    Ann Allergy Asthma Immunol. 2022 May 19. pii: S1081-1206(22)00409.
    PubMed     Abstract available


  28. MENDY A, Mersha TB
    Comorbidities in Childhood-onset and Adult-Onset Asthma.
    Ann Allergy Asthma Immunol. 2022 May 17. pii: S1081-1206(22)00410.
    PubMed     Abstract available


  29. POLINSKI KJ, Bell GA, Trinh MH, Sundaram R, et al
    Maternal obesity, gestational weight gain and offspring asthma and atopy.
    Ann Allergy Asthma Immunol. 2022 May 9. pii: S1081-1206(22)00397.
    PubMed     Abstract available


  30. WILSON K, Gebretsadik T, Adgent MA, Loftus C, et al
    The association between duration of breastfeeding and childhood asthma outcomes.
    Ann Allergy Asthma Immunol. 2022 May 9. pii: S1081-1206(22)00400.
    PubMed     Abstract available


  31. YAMANE M, Ohnishi H, Tsuji K, Anabuki K, et al
    Dupilumab-induced peripheral neuropathy in a patient with severe asthma.
    Ann Allergy Asthma Immunol. 2022;128:611.
    PubMed    


  32. GALANT SP, Morphew T, Ehwerhemuepha L
    Reduced exposure to respiratory viral triggers may explain less health care utilization for children with asthma.
    Ann Allergy Asthma Immunol. 2022;128:486-487.
    PubMed    


  33. WHITE AA
    If aspirin-exacerbated respiratory disease treatment is a jigsaw puzzle, where do the aspirin and biologic pieces go?
    Ann Allergy Asthma Immunol. 2022;128:484-485.
    PubMed    


  34. GRAYSON MH
    New! American College of Allergy, Asthma and Immunology Annals fellow-in-training award program.
    Ann Allergy Asthma Immunol. 2022;128:483.
    PubMed    


  35. SPERGEL BL, Ruffner MA, Godwin BC, Liacouras CA, et al
    Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use.
    Ann Allergy Asthma Immunol. 2022;128:589-593.
    PubMed     Abstract available


    April 2022
  36. HASAN ARSHAD S
    Does allergen Immunotherapy for allergic rhinitis prevent asthma?
    Ann Allergy Asthma Immunol. 2022 Apr 29. pii: S1081-1206(22)00392.
    PubMed     Abstract available


  37. WONG M, Forno E, Celedon JC
    Asthma: interactions between obesity and other risk factors.
    Ann Allergy Asthma Immunol. 2022 Apr 29. pii: S1081-1206(22)00394.
    PubMed     Abstract available


  38. NIESSEN NM, Fricker M, McDonald VM, Gibson PG, et al
    T2-low: What do we know? - Past, present, and future of biologic therapies in non-eosinophilic asthma.
    Ann Allergy Asthma Immunol. 2022 Apr 26. pii: S1081-1206(22)00342.
    PubMed     Abstract available


  39. CIPRANDI G, Schiavetti I, Cioffi L, Pane M, et al
    The PRObiotics in Pediatric Asthma Management (PROPAM) study: a post-hoc analysis in allergic children.
    Ann Allergy Asthma Immunol. 2022 Apr 26. pii: S1081-1206(22)00391.
    PubMed    


  40. ELDEIRAWI KM, Nyenhuis SM, Huntington-Moskos L, Polivka BJ, et al
    COVID-19 Related Anxiety Is Associated with Uncontrolled Asthma in Adults.
    Ann Allergy Asthma Immunol. 2022 Apr 22. pii: S1081-1206(22)00308.
    PubMed    


  41. WINSLOW A, Keet C
    Preventing Allergies Through the Skin.
    Ann Allergy Asthma Immunol. 2022 Apr 22. pii: S1081-1206(22)00311.
    PubMed     Abstract available


  42. ZHANG H, Xian M, Shi X, Luo T, et al
    Blocking function of allergen-specific IgG, F(ab')2, and Fab antibodies prepared from patients undergoing Dermatophagoides pteronyssinus immunotherapy.
    Ann Allergy Asthma Immunol. 2022 Apr 8. pii: S1081-1206(22)00293.
    PubMed     Abstract available


  43. ALABDULKARIM N, Gai J, Bost J, Pillai D, et al
    Effect of the COVID-19 pandemic on morbidity among children hospitalized for an asthma exacerbation.
    Ann Allergy Asthma Immunol. 2022 Apr 7. pii: S1081-1206(22)00294.
    PubMed     Abstract available


  44. CROPPER KJ, Davis BE, Cockcroft DW
    Effect of daily tiotropium on allergen-induced early asthmatic responses and airway inflammation.
    Ann Allergy Asthma Immunol. 2022 Apr 5. pii: S1081-1206(22)00296.
    PubMed    


  45. OPPENHEIMER J, Leung DYM
    Asthma 2022-moving toward precision medicine.
    Ann Allergy Asthma Immunol. 2022;128:343.
    PubMed    


  46. BORISH L
    Rethinking the central role of mast cells in virally-mediated asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Apr 1. pii: S1081-1206(22)00288.
    PubMed    


  47. MISS OZUNA L, Ryan T, Bensko JC, Laidlaw TM, et al
    Dupilumab-associated arthralgia in patients with aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2022;128:469-472.
    PubMed    


    March 2022
  48. HOWELL D, Rogers L, Kasarskis A, Twyman K, et al
    Comparison and Validation of Algorithms for Asthma Diagnosis in an Electronic Medical Record System.
    Ann Allergy Asthma Immunol. 2022 Mar 30. pii: S1081-1206(22)00285.
    PubMed     Abstract available


  49. MACDONALD M, Chang WC, Martin LJ, Hershey GKK, et al
    The Pediatric Asthma Risk Score (PARS): more does not mean better.
    Ann Allergy Asthma Immunol. 2022 Mar 29. pii: S1081-1206(22)00284.
    PubMed    


  50. KIMURA H, Shimizu K, Tanabe N, Makita H, et al
    Further evidence for association of YKL-40 with severe asthma airway remodeling.
    Ann Allergy Asthma Immunol. 2022 Mar 24. pii: S1081-1206(22)00207.
    PubMed     Abstract available


  51. LUDWIG A, Brehm C, Fung C, Jia S, et al
    Asthma and COVID-19 related outcomes in hospitalized patients: A single center experience.
    Ann Allergy Asthma Immunol. 2022 Mar 24. pii: S1081-1206(22)00208.
    PubMed     Abstract available


  52. OPPENHEIMER J, Hoyte FCL, Phipatanakul W, Silver J, et al
    Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions.
    Ann Allergy Asthma Immunol. 2022 Mar 7. pii: S1081-1206(22)00170.
    PubMed     Abstract available


  53. ADEJUMO I, Patel M, McKeever TM, Shaw DE, et al
    Does inhaler technology improve adherence and asthma control? A pilot randomised controlled trial.
    Ann Allergy Asthma Immunol. 2022 Mar 4. pii: S1081-1206(22)00169.
    PubMed    


  54. WANG Y, Guo D, Chen X, Wang S, et al
    Trends in asthma among adults in the United States, NHANES 2005-2018.
    Ann Allergy Asthma Immunol. 2022 Mar 4. pii: S1081-1206(22)00168.
    PubMed    


  55. PATEL P, Bensko JC, Bhattacharyya N, Laidlaw TM, et al
    Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2022;128:326-328.
    PubMed    


    February 2022
  56. KOINIS-MITCHELL D, D'Angelo C, Dunsiger S, McQuaid E, et al
    Effects of COVID-19 Pandemic on Children, Adolescents and Young Adults with Asthma in Rhode Island: Patterns in Emergency Department Utilization with Geospatial Mapping.
    Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00120.
    PubMed     Abstract available


  57. MACIAG MC, Phipatanakul W
    Update on Indoor Allergens and Their Impact on Pediatric Asthma.
    Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00119.
    PubMed     Abstract available


  58. RAMEY OL, Silva Almodovar A, Nahata MC
    Medication Adherence in Medicare Enrolled Older Adults with Asthma Before and During the COVID-19 Pandemic.
    Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00121.
    PubMed     Abstract available


  59. MELHORN DJ, Howell DI, Pavord PID
    Should we apply a treatable traits approach to asthma care?
    Ann Allergy Asthma Immunol. 2022 Feb 13. pii: S1081-1206(22)00098.
    PubMed     Abstract available


  60. SEHAYEK D, Gold MS, Gabrielli S, Abrams EM, et al
    Seafood-Induced Anaphylaxis in Children Presenting to Canadian Emergency Departments: Rates, Clinical Presentation and Management.
    Ann Allergy Asthma Immunol. 2022 Feb 13. pii: S1081-1206(22)00097.
    PubMed     Abstract available


  61. ENG V, Moreno GP, Chang J, Liebhaber M, et al
    A Pediatric Asthma Camp Experience during the COVID-19 Pandemic.
    Ann Allergy Asthma Immunol. 2022 Feb 4. pii: S1081-1206(22)00087.
    PubMed    


  62. MULLUR J, Steger CM, Gakpo D, Bensko JC, et al
    Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease: Efficacy, tolerability, and patient experience.
    Ann Allergy Asthma Immunol. 2022 Feb 4. pii: S1081-1206(22)00090.
    PubMed     Abstract available


  63. CHIPPS BE, Murphy KR, Wise RA, McCann WA, et al
    Assessing Construct Validity of the Asthma Impairment and Risk Questionnaire Using a 3-month Exacerbation Recall.
    Ann Allergy Asthma Immunol. 2022 Feb 2. pii: S1081-1206(22)00081.
    PubMed     Abstract available


  64. GUILBERT TW, Biagini JM, Ramsey RR, Keidel K, et al
    Treatment by Biomarker-Informed Endotype Versus Guideline Care in Children with Difficult to Treat Asthma.
    Ann Allergy Asthma Immunol. 2022 Feb 2. pii: S1081-1206(22)00076.
    PubMed    


    January 2022
  65. STOUT S, Murphy H, Pandya A, Yeh HW, et al
    The Effect of COVID-19 on Asthma Visits.
    Ann Allergy Asthma Immunol. 2022 Jan 28. pii: S1081-1206(22)00048.
    PubMed    


  66. GENG B, Dixon AE, Ko J, Janampally P, et al
    Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma.
    Ann Allergy Asthma Immunol. 2022 Jan 28. pii: S1081-1206(22)00045.
    PubMed     Abstract available


  67. WANG E, Wechsler ME
    A Rational Approach to Compare and Select Biologic Therapeutics in Asthma.
    Ann Allergy Asthma Immunol. 2022 Jan 27. pii: S1081-1206(22)00046.
    PubMed     Abstract available


  68. POPOV TA, Hristova D, Kralimarkova TZ, Mustakov TB, et al
    Time course of disease characteristics in subjects with severe allergic asthma starting treatment with omalizumab.
    Ann Allergy Asthma Immunol. 2022 Jan 24. pii: S1081-1206(22)00024.
    PubMed    


  69. DROUIN O, Smyrnova A, Betinjane N, Ducharme FM, et al
    Adherence to inhaled corticosteroids prescribed once- vs twice-daily in children with asthma.
    Ann Allergy Asthma Immunol. 2022 Jan 22. pii: S1081-1206(22)00022.
    PubMed     Abstract available


  70. MUISER S, Gosens R, van den Berge M, Kerstjens HAM, et al
    Understanding the role of long-acting muscarinic antagonists in asthma treatment.
    Ann Allergy Asthma Immunol. 2022 Jan 21. pii: S1081-1206(22)00017.
    PubMed     Abstract available


  71. ESCHENBACHER W, Kim M, Mattos J, Lawrence M, et al
    Activation of platelet-adherent basophils in chronic rhinosinusitis with alcohol hypersensitivity.
    Ann Allergy Asthma Immunol. 2022 Jan 18. pii: S1081-1206(22)00014.
    PubMed     Abstract available


  72. FENG X, Lawrence MG, Payne SC, Mattos J, et al
    Lower viral loads in rhinovirus-challenged allergic subjects despite reduced innate immunity.
    Ann Allergy Asthma Immunol. 2022 Jan 12. pii: S1081-1206(22)00010.
    PubMed     Abstract available


  73. VISWAM D, Mansur AH
    Mode of onset and triggers of severe asthma; the severe asthma clinic perspective.
    Ann Allergy Asthma Immunol. 2022 Jan 11. pii: S1081-1206(22)00008.
    PubMed    


  74. WONG M, Han YY, Rosser F, Acosta-Perez E, et al
    Persistent overweight or obesity, lung function, and asthma exacerbations in Puerto Rican Youth.
    Ann Allergy Asthma Immunol. 2022 Jan 8. pii: S1081-1206(22)00005.
    PubMed     Abstract available


  75. LOBATO M, Gaspar-Marques J, Carreiro-Martins P, Pinto PL, et al
    Secondary adrenal suppression related to high doses of inhaled corticosteroids in severe asthma patients.
    Ann Allergy Asthma Immunol. 2022 Jan 7. pii: S1081-1206(22)00002.
    PubMed    


  76. BACHARIER LB
    Asthma Guidelines: Where to next?: A Perspective for Annals of Allergy, Asthma & Immunology.
    Ann Allergy Asthma Immunol. 2022 Jan 5. pii: S1081-1206(21)01342.
    PubMed    


  77. WANG E, Zahid S, Moudgal AN, Demaestri S, et al
    Intimate Partner Violence and Asthma in Pediatric and Adult Populations: A Systematic Review.
    Ann Allergy Asthma Immunol. 2022 Jan 4. pii: S1081-1206(21)01343.
    PubMed     Abstract available


  78. LAWRENCE MG, Teague WG, Feng X, Welch C, et al
    Interleukin-5 receptor alpha (CD125) expression on human blood and lung neutrophils.
    Ann Allergy Asthma Immunol. 2022;128:53-60.
    PubMed     Abstract available


    December 2021
  79. BURROWS AG, Ellis AK
    Psychological Impacts of COVID-19 on people with Asthma, Allergic Rhinitis and Food Allergy.
    Ann Allergy Asthma Immunol. 2021 Dec 28. pii: S1081-1206(21)01310.
    PubMed    


  80. FISCHELL SZ, Fischell JM, Olexa G, Callahan C, et al
    Impact of COVID-19 pandemic on frequency and severity of asthma exacerbations in an inner-city population.
    Ann Allergy Asthma Immunol. 2021 Dec 16. pii: S1081-1206(21)01308.
    PubMed    


    November 2021
  81. CORREN J, Silver J, Molfino NA, Bogart M, et al
    A real-world study of ICS use in patients with severe eosinophilic asthma treated with mepolizumab.
    Ann Allergy Asthma Immunol. 2021 Nov 10. pii: S1081-1206(21)01219.
    PubMed     Abstract available


  82. LU MA, Eckmann T, Ruvalcaba E, McQuaid EL, et al
    Family Management of Asthma in Head Start Preschool Children.
    Ann Allergy Asthma Immunol. 2021 Nov 10. pii: S1081-1206(21)01217.
    PubMed     Abstract available


  83. CARR TF
    Treatment approaches for the patient with T2 low asthma.
    Ann Allergy Asthma Immunol. 2021;127:530-535.
    PubMed     Abstract available


  84. OPPENHEIMER JJ, Leung DYM
    Asthma, in quest of optimizing care.
    Ann Allergy Asthma Immunol. 2021;127:517.
    PubMed    


  85. LEVERONE N, Tran S, Barry J, Akuthota P, et al
    Diagnoses associated with peripheral blood eosinophilia: A 5-year review.
    Ann Allergy Asthma Immunol. 2021;127:597-598.
    PubMed    


    October 2021
  86. LAFORCE C, Chipps BE, Albers FC, Reilly L, et al
    Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study.
    Ann Allergy Asthma Immunol. 2021 Oct 23. pii: S1081-1206(21)01169.
    PubMed     Abstract available


  87. GRANT T, Croce E, Matsui E
    Asthma and the Social Determinants of Health.
    Ann Allergy Asthma Immunol. 2021 Oct 18. pii: S1081-1206(21)01132.
    PubMed     Abstract available


  88. AVDEEV SN, Pozdnakova AA, Gaynitdinova VV, Chikina SY, et al
    Asthma in older adults with severe COVID-19: clinical outcomes and predictors of mortality.
    Ann Allergy Asthma Immunol. 2021 Oct 17. pii: S1081-1206(21)01163.
    PubMed    


  89. HOSSAIN R, Zhao F, Michenkova M, Kaelber D, et al
    Trends in racial disparities in asthma emergency department utilization during COVID-19.
    Ann Allergy Asthma Immunol. 2021 Oct 12. pii: S1081-1206(21)01159.
    PubMed    


  90. TORRE AB, Dasgupta R, Eldeirawi KM, Nyenhuis SM, et al
    Positive associations of pollutants and aeroallergens with allergic rhinitis in adults with asthma.
    Ann Allergy Asthma Immunol. 2021 Oct 11. pii: S1081-1206(21)01157.
    PubMed    


  91. STAMPFLI M, Frei R, Divaret-Chauveau A, Schmausser-Hechfellner E, et al
    Inverse associations between food diversity in the 2(nd) year of life and allergic diseases.
    Ann Allergy Asthma Immunol. 2021 Oct 11. pii: S1081-1206(21)01154.
    PubMed     Abstract available


  92. BLEECKER ER, Gandhi H, Gilbert I, Murphy KR, et al
    Mapping Geographic Variability of Severe Uncontrolled Asthma in the United States: Management Implications.
    Ann Allergy Asthma Immunol. 2021 Oct 7. pii: S1081-1206(21)01125.
    PubMed     Abstract available


    September 2021
  93. LAM RW, Inselman JW, Jeffery MM, Maddux JT, et al
    National decline in asthma exacerbations in US during COVID19 pandemic.
    Ann Allergy Asthma Immunol. 2021 Sep 25. pii: S1081-1206(21)01113.
    PubMed    


  94. SACO T, Ugalde IC, Cardet JC, Casale TB, et al
    Strategies for choosing a biologic for your patient with allergy or asthma.
    Ann Allergy Asthma Immunol. 2021 Sep 23. pii: S1081-1206(21)01035.
    PubMed     Abstract available


    July 2021
  95. BALL L, Velasquez SA, Jammal OMA, White AA, et al
    Atypical Eosinophilic Granulomatosis with Polyangiitis with Spontaneous Aspirin Reactivity and IgE Mediated Anaphylaxis.
    Ann Allergy Asthma Immunol. 2021 Jul 14. pii: S1081-1206(21)00502.
    PubMed    


  96. UDOKO M, De Keyser H, Szefler SJ
    Should Asthmatic Children Simply be Treated as Little Adults?
    Ann Allergy Asthma Immunol. 2021 Jul 11. pii: S1081-1206(21)00498.
    PubMed    


  97. FINEMAN S, Lee G, Hernandez-Truillo V, Chipps BE, et al
    From the Pages of Allergy Watch.
    Ann Allergy Asthma Immunol. 2021 Jul 8. pii: S1081-1206(21)00490.
    PubMed    


    May 2021
  98. ABRAMS EM, Greenhawt M, Shaker M, Kosowan L, et al
    Primary Care Provider-Reported Prevalence of Vaccine and Polyethylene-Glycol Allergy in Canada.
    Ann Allergy Asthma Immunol. 2021 May 15. pii: S1081-1206(21)00357.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: